Clinical Trial Update: Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of adding Teneligliptin in adults with Type 2 diabetes inadequately controlled on empagliflozin and metformin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Teneligliptin (Teneligliptin)

Snippet

Sponsor: Handok Inc. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED